BrainEver

Saint-antoine, France

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

$38.9M raised

Jul 2025

Series B

Top Investors

Critical Path VenturesEuropean Innovation CounciliBionextRelyens

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BrainEver raised?

BrainEver has raised $38.9M in total funding. The most recent round was Series B. The last funding was announced in July 2025.

Who are BrainEver's investors?

BrainEver's investors include Critical Path Ventures, European Innovation Council, iBionext, Relyens.

Where is BrainEver headquartered?

BrainEver is headquartered in Saint-antoine, France.

What does BrainEver do?

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

What stage is BrainEver at?

BrainEver is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 3, 2025.

MLA

"BrainEver — Funding & Investors." VCBacked, July 3, 2025, https://www.vcbacked.co/company/brainever. Accessed June 4, 2026.

APA

VCBacked. (2025). BrainEver — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/brainever

Wikipedia (cite web)

{{cite web |title=BrainEver — Funding & Investors |url=https://www.vcbacked.co/company/brainever |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 3, 2025.